Rossi Shannan L, Ross Ted M, Evans Jared D
Department of Microbiology and Molecular Genetics, Center for Vaccine Research, University of Pittsburgh, PA 15261, USA.
Clin Lab Med. 2010 Mar;30(1):47-65. doi: 10.1016/j.cll.2009.10.006.
West Nile virus (WNV) is responsible for thousands of cases of morbidity and mortality in birds, horses, and humans. Epidemics were localized to Europe, Africa, the Middle East, and parts of Asia, and primarily caused a mild febrile illness in humans. In the late 1990s, the virus became more virulent and spread to North America. In humans, the clinical presentation ranges from asymptomatic, seen frequently, to encephalitis/paralysis and death, seen rarely. There is no FDA (Food and Drug Administration)-licensed vaccine for human use, and the only recommended treatment is supportive care. Often, there is a long recovery period. This article reviews the current literature summarizing the molecular virology, epidemiology, clinical manifestations, pathogenesis, diagnosis, treatment, immunology, and protective measures against WNV and WNV infections in humans.
西尼罗河病毒(WNV)导致鸟类、马匹和人类出现数千例发病和死亡病例。疫情曾局限于欧洲、非洲、中东和亚洲部分地区,主要在人类中引起轻度发热疾病。20世纪90年代末,该病毒变得更具毒性并传播到北美。在人类中,临床表现从常见的无症状到罕见的脑炎/瘫痪和死亡不等。目前尚无美国食品药品监督管理局(FDA)批准的用于人类的疫苗,唯一推荐的治疗方法是支持性护理。通常,恢复期较长。本文综述了当前文献,总结了西尼罗河病毒及其在人类中的感染的分子病毒学、流行病学、临床表现、发病机制、诊断、治疗、免疫学和预防措施。